Sandoz Group (OTCMKTS:SDZNY) Reaches New 12-Month High – Here’s What Happened

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY)’s stock price hit a new 52-week high during trading on Wednesday . The stock traded as high as $73.71 and last traded at $73.50, with a volume of 10378 shares traded. The stock had previously closed at $72.77.

Wall Street Analysts Forecast Growth

Separately, Barclays raised Sandoz Group to a “strong-buy” rating in a research note on Monday, October 13th. One investment analyst has rated the stock with a Strong Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy”.

Sandoz Group Price Performance

The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.82 and a current ratio of 1.29. The company has a 50-day moving average of $65.54 and a 200-day moving average of $60.05.

About Sandoz Group

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.